(MedPage Today) — An FDA advisory committee voted Thursday to remove compounding restrictions on two peptides — BPC-157 and KPV — despite little evidence the products are safe or effective for medical use.
BPC-157, touted by wellness influencers…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
